АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология
|
Приложение 22
ТОЛЩИНА ЗАЩИТНОГО ЭКРАНА ИЗ СВИНЦА В ЗАВИСИМОСТИ ОТ КРАТНОСТИ ОСЛАБЛЕНИЯ И ЭНЕРГИИ Ύ-ИЗЛУЧЕНИЯ (ШИРОКИЙ ПУЧОК), ММ
(Руководство к лабораторным занятиям по гигиене и основам экологии человека. Пивоваров Ю. П. М. 2006г.)
Кратность ослабления
| Энергия Ύ-излучения
| 0,1
| 0,2
| 0,3
| 0,4
| 0,5
| 0,6
| 0,7
| 0,8
| 0,9
| 1,0
| 1,25
| 1,5
| 1,75
| 2,0
| 2,5
| 3,0
| 4,0
| 6,0
| 8,0
| 10,0
| 1,5
| 0,5
| 1,0
| 1,5
| 2,0
| 2,0
| 3,0
| 4,0
| 6,0
| 7,0
| 8,0
| 9,5
| 11,0
| 12,0
| 12,0
| 12,0
| 13,0
| 12,0
| 10,0
| 9,0
| 9,0
|
| 1,0
| 2,0
| 3,0
| 4,0
| 5,0
| 7,0
| 8,0
| 10,0
| 11,5
| 13,0
| 15,0
| 17,0
| 18,5
| 20,0
| 20,0
| 21,0
| 20,0
| 16,0
| 15,0
| 13,5
|
| 2,0
| 4,0
| 6,0
| 9,0
| 11,0
| 15,0
| 19,0
| 22,0
| 25,0
| 28,0
| 34,0
| 33,0
| 41,0
| 43,0
| 44,0
| 46,0
| 45,0
| 38,0
| 33,0
| 30,0
|
| 2,0
| 5,0
| 8,0
| 11,0
| 15,0
| 19,5
| 23,5
| 28,0
| 32,0
| 35,0
| 42,0
| 48,0
| 52,5
| 55,0
| 57,0
| 59,0
| 58,0
| 50,0
| 43,0
| 38,0
|
| 3,0
| 5,5
| 9,0
| 13,0
| 16,0
| 21,0
| 26,0
| 30,5
| 35,5
| 38,0
| 45,0
| 51,0
| 56,0
| 59,0
| 61,0
| 65,0
| 64,0
| 55,0
| 49,0
| 42,0
|
| 3,0
| 6,0
| 11,0
| 15,0
| 20,0
| 26,0
| 32,5
| 38,5
| 44,0
| 49,0
| 58,0
| 66,0
| 72,0
| 76,0
| 78,0
| 83,0
| 82,0
| 71,0
| 63,0
| 56,0
|
| 3,5
| 7,0
| 11,5
| 17,0
| 23,0
| 30,0
| 36,5
| 43,0
| 49,5
| 55,0
| 65,0
| 73,0
| 80,0
| 85,0
| 88,0
| 93,0
| 92,0
| 80,0
| 72,0
| 63,0
|
| 4,0
| 8,0
| 13,0
| 18,0
| 24,0
| 31,0
| 38,0
| 45,0
| 52,0
| 58,0
| 68,5
| 78,0
| 86,0
| 91,0
| 91,0
| 100,0
| 99,0
| 87,0
| 78,0
| 68,0
|
| 4,0
| 8,5
| 14,0
| 19,5
| 26,0
| 32,5
| 39,5
| 46,0
| 53,0
| 60,0
| 72,0
| 82,0
| 90,0
| 96,0
| 100,0
| 106,0
| 105,0
| 92,0
| 83,0
| 73,0
|
| 4,5
| 9,0
| 14,5
| 20,5
| 27,0
| 34,5
| 42,0
| 49,5
| 56,0
| 63,0
| 75,0
| 85,0
| 95,0
| 101,0
| 104,0
| 110,0
| 109,0
| 97,0
| 87,0
| 77,0
|
| 4,5
| 10,0
| 15,5
| 21,5
| 28,0
| 37,0
| 45,0
| 53,0
| 60,0
| 67,0
| 80,0
| 92,0
| 101,0
| 107,0
| 111,0
| 117,0
| 116,0
| 104,0
| 94,0
| 82,0
|
| 5,0
| 10,0
| 16,0
| 23,0
| 30,0
| 38,5
| 47,0
| 55,0
| 63,0
| 70,0
| 84,5
| 96,5
| 106,0
| 113,0
| 117,0
| 122,0
| 121,0
| 109,0
| 99,0
| 87,0
|
20. Введение радиофармацевтических средств с целью диагностики, и особенно, терапии, беременным женщинам не допускается.
21. При введении с целью диагностики или терапии радиофармацевтических препаратов кормящим матерям должно быть временно приостановлено кормление ребенка грудью. Срок прекращения грудного кормления зависит от вида и количества вводимого препарата и определяется отдельными инструкциями.
Приложение 23
Дата добавления: 2014-12-11 | Просмотры: 769 | Нарушение авторских прав
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 |
|